Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3

Human Gene Therapy

Volumn 21, Issue 12, 2010, Pages 1741-1747

  Ling, Chen ^a   Lu, Yuan ^a   Kalsi, Jasmine K ^a   Jayandharan, Giridhara R ^a,b   Li, Baozheng ^a   Ma, Wenqin ^a   Cheng, Binbin ^a   Gee, Samantha W Y ^a   McGoogan, Katherine E ^a   Govindasamy, Lakshmanan ^a   Zhong, Li ^c   Agbandje Mckenna, Mavis ^a   Srivastava, Arun ^a,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; RECEPTOR ANTIBODY; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS TYPE 3; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; TRANSGENE; VIRUS ENTRY;

ANIMALS; BINDING SITES; CELL LINE; CELL LINE, TUMOR; DEPENDOVIRUS; DOWN-REGULATION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MET; RECEPTORS, GROWTH FACTOR; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; RNA INTERFERENCE; VIRAL TROPISM; VIRUS INTERNALIZATION;

ADENO-ASSOCIATED VIRUS; MURINAE;

EID: 78650105132     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.075     Document Type: Article

References (43)

1. Akache, B., Grimm, D., Pandey, K., Yant, S.R., Xu, H., and Kay, M.A. (2006). The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 80, 9831-9836. (Pubitemid 44435657)
2. 1 binding domain essential for viral cell entry. J. Virol. 80, 8961-8969. (Pubitemid 44359970)
3. Auricchio, A., Hildinger, M., O'Connor, E., Gao, G.P., and Wilson, J.M. (2001). Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther. 12, 71-76. (Pubitemid 32044468)
4. Blackburn, S.D., Steadman, R.A., and Johnson, F.B. (2006). Attachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1. Arch. Virol. 151, 617-623.
5. Chen, T.T., Rakheja, D., Hung, J.Y., Hornsby, P.J., Tabaczewski, P., Malogolowkin, M., Feusner, J., Miskevich, F., Schultz, R., and Tomlinson, G.E. (2009). Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor. Pediatr. Blood Cancer 53, 1040-1047.
6. Chiorini, J.A., Yang, L., Liu, Y., Safer, B., and Kotin, R.M. (1997). Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J. Virol. 71, 6823-6833. (Pubitemid 27355343)
7. Chiorini, J.A., Kim, F., Yang, L., and Kotin, R.M. (1999). Cloning and characterization of adeno-associated virus type 5. J. Virol. 73, 1309-1319. (Pubitemid 29036786)
8. Daya, S., and Berns, K.I. (2008). Gene therapy using adeno-associated virus vectors. Clin. Microbiol. Rev. 21, 583-593.
9. Di Pasquale, G., Davidson, B.L., Stein, C.S., Martins, I., Scudiero, D., Monks, A., and Chiorini, J.A. (2003). Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med. 9, 1306-1312. (Pubitemid 37279855)
10. Gao, G., Vandenberghe, L.H., Alvira, M.R., Lu, Y., Calcedo, R., Zhou, X., and Wilson, J.M. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388. (Pubitemid 38715936)
11. Gao, G.P., Alvira, M.R., Wang, L., Calcedo, R., Johnston, J., and Wilson, J.M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859. (Pubitemid 34994488)
12. Glushakova, L.G., Lisankie, M.J., Eruslanov, E.B., Ojano-Dirain, C., Zolotukhin, I., Liu, C., Srivastava, A., and Stacpoole, P.W. (2009). AAV3-mediated transfer and expression of the pyru-vate dehydrogenase E1a subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells. Mol. Genet. Metab. 98, 289-299.
13. Grigioni, W.F., Fiorentino, M., D'Errico, A., Ponzetto, A., Crepaldi, T., Prat, M., and Comoglio, P.M. (1995). Over-expression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions. Hepatology 21, 1543-1546.
14. Jayandharan, G.R., Zhong, L., Sack, B.K., Rivers, A.E., Li, M., Li, B., Herzog, R., and Srivastava, A. (2010). Optimized adeno-associated virus (AAV)-protein phosphatase-S helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses. Hum. Gene Ther. 21, 271-283.
15. Kaludov, N., Brown, K.E., Walters, R.W., Zabner, J., and Chiorini, J.A. (2001). Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hem-agglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75, 6884-6893. (Pubitemid 32641575)
16. Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shima-da, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., and Daida, H. (2005). Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J. Virol. 79, 609-614. (Pubitemid 39648414)
17. Kauss, M.A., Smith, L.J., Zhong, L., Srivastava, A., Wong, K.K. Jr., and Chatterjee, S. (2010). Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2. Hum. Gene Ther. 21, 1129-1136.
18. Kube, D.M., and Srivastava, A. (1997). Quantitative DNA slot blot analysis: Inhibition of DNA binding to membranes by magnesium ions. Nucleic Acids Res. 25, 3375-3376. (Pubitemid 27338702)
19. Kurzeder, C., Koppold, B., Sauer, G., Pabst, S., Kreienberg, R., and Deissler, H. (2007). CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans. Int. J. Mol. Med. 19, 325-333.
20. Li, M., Jayandharan, G.R., Li, B., Ling, C., Ma, W., Srivastava, A., and Zhong, L. (2010). High-efficiency transduction of fibro-blasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy. Hum. Gene Ther. 21, 1527-1543.
21. Markusic, D.M., Herzog, R.W., Aslanidi, G.V., Hoffman, B.E., Li, B., Li, M., Jayandharan, G.R., Ling, C., Zolotukhin, I., Ma, W., Zolotukhin, S., Srivastava, A., and Zhong, L. (2010). High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyr-osines. Mol. Ther. Aug 24. [Epub ahead of print] PMID: 20736929.
22. Muramatsu, S., Mizukami, H., Young, N.S., and Brown, K.E. (1996). Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology 221, 208-217. (Pubitemid 26266557)
23. Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T., and Sato, J. (1982). Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42, 3858-3863. (Pubitemid 12054507)
24. Ojano-Dirain, C., Glushakova, L.G., Zhong, L., Zolotukhin, S., Muzyczka, N., Srivastava, A., and Stacpoole, P.W. (2010). An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1a. Mol. Genet. Metab. 101, 183-191.
25. Okano, J., Shiota, G., and Kawasaki, H. (1999). Expression of hepatocyte growth factor (HGF) and HGF receptor (c-Met) proteins in liver diseases: An immunohistochemical study. Liver 19, 151-159. (Pubitemid 29139769)
26. Petrs-Silva, H., Dinculescu, A., Li, Q., Min, S.H., Chiodo, V., Pang, J.J., Zhong, L., Zolotukhin, S., Srivastava, A., Lewin, A.S., and Hauswirth, W.W. (2009). High-efficiency transduc-tion of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol. Ther. 17, 463-471.
27. Petrs-Silva, H., Dinculescu, A., Li, Q., Deng, W.T., Pang, J.J., Min, S.H., Chiodo, V., Neeley, A.W., Govindasamy, L., Bennett, A., Agbandje-McKenna, M., Zhong, L., Li, B., Jayandharan, G.R., Srivastava, A., Lewin, A.S., and Hauswirth, W.W. (2010). Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Mol. Ther. Nov 2. [Epub ahead of print] PMID: 21045809.
28. Ponnazhagan, S., Wang, X.S., Woody, M.J., Luo, F., Kang, L.Y., Nallari, M.L., Munshi, N.C., Zhou, S.Z., and Srivastava, A. (1996). Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid trans-fection and recombinant adeno-associated virus 2 (AAV) infection: Human megakaryocytic leukaemia cells are non-permissive for AAV infection. J. Gen. Virol. 77, 1111-1122.
29. Qiao, C., Zhang, W., Yuan, Z., Shin, J.H., Li, J., Jayandharan, G.R., Zhong, L., Srivastava, A., Xiao, X., and Duan, D. (2010). Adeno-associated virus serotype 6 capsid tyrosine-to-phenyl-alanine mutations improve gene transfer to skeletal muscle. Hum. Gene Ther. 21, 1343-1348.
30. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., and Sri-vastava, A. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5, 71-77. (Pubitemid 29051001)
31. Rabinowitz, J.E., Bowles, D.E., Faust, S.M., Ledford, J.G., Cunningham, S.E., and Samulski, R.J. (2004). Cross-dressing the virion: The transcapsidation of adeno-associated virus sero-types functionally defines subgroups. J. Virol. 78, 4421-4432. (Pubitemid 38501062)
32. Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S., and Vande Woude, G.F. (1992). Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol. 12, 5152-5158.
33. Rutledge, E.A., Halbert, C.L., and Russell, D.W. (1998). Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72, 309-319. (Pubitemid 28048842)
34. Stamos, J., Lazarus, R.A., Yao, X., Kirchhofer, D., and Wies-mann, C. (2004). Crystal structure of the HGF b-chain in complex with the Sema domain of the Met receptor. EMBO J. 23, 2325-2335. (Pubitemid 38954840)
35. Summerford, C., and Samulski, R.J. (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438-1445. (Pubitemid 28116931)
36. 5 integrin: A co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5, 78-82. (Pubitemid 29051002)
37. Thomas, C.E., Storm, T.A., Huang, Z., and Kay, M.A. (2004). Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J. Virol. 78, 3110-3122. (Pubitemid 38314369)
38. Walters, R.W., Yi, S.M., Keshavjee, S., Brown, K.E., Welsh, M.J., Chiorini, J.A., and Zabner, J. (2001). Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276, 20610-20616.
39. Weller, M.L., Amornphimoltham, P., Schmidt, M., Wilson, P.A., Gutkind, J.S., and Chiorini, A. (2010). Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6. Nat. Med. 16, 662-664.
40. Wu, J., Zhao, W., Zhong, L., Han, Z., Li, B., Ma, W., Weigel-Kelley, K.A., Warrington, K.H., and Srivastava, A. (2007). Self-complementary recombinant adeno-associated viral vectors: Packaging capacity and the role of Rep proteins in vector purity. Hum. Gene Ther. 18, 171-182. (Pubitemid 46446054)
41. Wu, Z., Miller, E., Agbandje-McKenna, M., and Samulski, R.J. (2006). a2,3 and a2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 80, 9093-9103. (Pubitemid 44359983)
42. Zhong, L., Li, B., Mah, C.S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R.W., Zolotukhin, I., Warrington, K.H., Jr., Weigel-Van Aken, K.A., Hobbs, J.A., Zolotukhin, S., Muzyczka, N., and Srivastava, A. (2008). Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc. Natl. Acad. Sci. U.S.A. 105, 7827-7832. (Pubitemid 351872723)
43. Zincarelli, C., Soltys, S., Rengo, G., and Rabinowitz, J.E. (2008). Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073-1080. (Pubitemid 351737072)